Molecular Imaging: Page 186

SNMMI: PET/CT with prostate agent changes therapy plans

By AuntMinnie.com staff writers

Australian researchers found that treatment plans for more than half of prostate cancer patients were changed due to the results of PET/CT scans using a radiopharmaceutical that combines gallium-68 with a molecular compound that homes in on prostate-specific membrane antigen, according to a study presented at this week's Society of Nuclear Medicine and Molecular Imaging (SNMMI) meeting.

June 13, 2017

SNMMI taps new slate of officers for 2017-2018

By AuntMinnie.com staff writers

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has announced a new slate of officers for the coming year at its annual meeting in Denver.

June 13, 2017

SNMMI: PET/ultrasound targets recurrent prostate cancer

By Wayne Forrest

DENVER - Researchers at Emory University are reporting early success in fusing fluciclovine-PET and 3D ultrasound images to better detect and biopsy suspected recurrent prostate cancer. They presented their findings at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) meeting.

June 13, 2017

SNMMI: 2-for-1 PET detects dual Alzheimer's markers

By AuntMinnie.com staff writers

A PET protocol in which two scans are conducted after injection of one radiopharmaceutical holds the promise of detecting two clinical markers for Alzheimer's disease, according to research presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting this week.

June 13, 2017

High amyloid levels on PET may indicate early Alzheimer's

By Kate Madden Yee

Elevated levels of amyloid on PET scans of the brain have been associated with an increased risk for Alzheimer's disease. But a study published June 13 in the Journal of the American Medical Association suggests that higher levels of amyloid could actually be the first preclinical sign of the illness.

June 13, 2017

SNMMI: Theranostic agent targets pancreatic cancer

By AuntMinnie.com staff writers

A monoclonal antibody-based agent could prove useful for diagnosing and treating patients with pancreatic cancer, according to research presented this week at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) meeting.

June 12, 2017

News from SNMMI | PET for Alzheimer's | Deep learning for PICC lines

By Brian Casey

June 12, 2017

SNMMI: SPECT shows brain changes in football players

By Wayne Forrest

DENVER - SPECT scans show changes in cerebral blood flow in retired professional football players that differ based on which position they played, according to researchers from the University of California, Los Angeles. The findings were presented on Monday at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) meeting.

June 12, 2017

Concussion researcher nets $25M for CTE program

By AuntMinnie.com staff writers

Noted concussion researcher Dr. Julian Bailes has been awarded new grant funding of up to $25 million for research on traumatic brain injury and chronic traumatic encephalopathy (CTE), according to an announcement on Sunday at the Society of Nuclear Medicine and Molecular Imaging meeting in Denver.

June 11, 2017

AuntMinnie.com Molecular Imaging Insider

By Wayne Forrest

June 11, 2017

Siemens gets FDA nod for Biograph Horizon Flow

By AuntMinnie.com staff writers

Siemens Healthineers has received U.S. Food and Drug Administration (FDA) clearance for its Biograph Horizon Flow PET/CT scanner.

June 11, 2017

SNMMI: FET-PET could have answers for brainstem glioma

By Wayne Forrest

DENVER - Researchers in Switzerland are setting their sights on fluoroethyl-tyrosine (FET) PET imaging as the best way to assess adult brainstem glioma and gauge patients' chances for progression-free survival. Study results were presented on Sunday at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.

June 11, 2017

Previous Page

Page 186 of 621

Next Page